Horst Lindhofer
20Patents
10h-index
14Co-inventors
72Inventor score
Filing activity: Nov 29, 1996 → Mar 23, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6551592B2 | Bi-and trispecific antibodies for the induction of anti-tumor immunity | Chemistry; Metallurgy | 157 | Expired |
| US5945311A | Method for producing heterologous bi-specific antibodies | Chemistry; Metallurgy | 137 | Expired |
| US7018632B2 | Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies | Chemistry; Metallurgy | 85 | Expired |
| US6994853B1 | Time-staggered utilization of tumor cells in combination with intact antibodies for immunization | Chemistry; Metallurgy | 80 | Expired |
| US8709421B2 | Combination of the application of antibodies for immunostimulation together with glucocorticoids | Chemistry; Metallurgy | 50 | Active |
| US5985276A | Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies | Chemistry; Metallurgy | 32 | Expired |
| US6210668A | Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies | Chemistry; Metallurgy | 29 | Expired |
| US9017676B2 | Destruction of tumor cells by trifunctional bispecific antibodies with low to medium expression levels of tumor-associated target antigens | Chemistry; Metallurgy | 28 | Active |
| US6294167A | Pharmaceutical compositions for immunotherapy containing antibodies which specifically recognize the MHCII antigen of a patient to be treated | Human Necessities | 19 | Expired |
| US8277806B2 | Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites | Chemistry; Metallurgy | 14 | Expired |
| US8663638B2 | Intraoperative trifunctional antibody application for prophylaxis of intraperitoneal tumor cell dissemination | Chemistry; Metallurgy | 7 | Active |
| US8066989B2 | Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy | Chemistry; Metallurgy | 6 | Expired |
| US6322787A | Induction of an anti-tumor immunity by redirecting tumor cells against antigen-presenting cells | Human Necessities | 3 | Expired |
| US9750806B2 | Vaccine preparation containing trifunctional antibodies with antigen immunogenicity enhancer properties | Chemistry; Metallurgy | 2 | Active |
| US9605242B2 | Removal of tumor cells from intraoperative autologous blood salvage | Chemistry; Metallurgy | 2 | Active |
| US6007807A | Induction of tumour immunity by injection of hybrid cells | Human Necessities | 2 | Expired |
| US9772327B2 | Initial relative lymphocyte count as predictive biomarker | Physics | 2 | Active |
| US8012470B2 | Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies | Chemistry; Metallurgy | 2 | Expired |
| US10071158B2 | Combination of the application of antibodies for immunostimulation together with glucocorticoids | Chemistry; Metallurgy | 1 | Active |
| US10576149B2 | Combination of the application of antibodies for immunostimulation together with glucocorticoids | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.